Literature DB >> 10868795

Construction of ELISA system to quantify human ST2 protein in sera of patients.

K Kuroiwa1, H Li, K Tago, H Iwahana, K Yanagisawa, N Komatsu, K Oshikawa, Y Sugiyama, T Arai, S I Tominaga.   

Abstract

The human ST2 gene can be specifically induced by growth stimulation in fibroblastic cells, and can also be induced by antigen stimulation in Th2 cells. The gene encodes a soluble secreted protein, ST2, and a transmembrane protein, ST2L, which are closely related to the interleukin-1 receptor. To gain insight into the biological roles of the ST2 gene, three monoclonal antibodies (MAbs) against human ST2 gene products were obtained. To obtain these antibodies, immunization was carried out using two different immunogens: purified soluble human ST2 protein (hST2), and COS7 cells, which express the extracellular portion of human ST2L. 2A5 and FB9 MAbs were derived from the immunization with soluble hST2, and HB12 was derived from the COS7 cell immunization. All three antibodies were shown to detect native forms of the human ST2 gene products by immunoprecipitation, flow cytometry, and enzyme-linked immunosorbent assay (ELISA). In the competitive ELISA using biotinylated and nonlabelled MAbs, neither FB9 nor HB12 affected the binding of 2A5 to ST2 gene products. Based on this result, we constructed a sandwich ELISA system using 2A5 and FB9 to measure the concentration of soluble hST2 in sera. The ELISA, combined with the flow cytometry using these antibodies, will be a useful tool for elucidating the functions of human ST2 gene products in individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868795     DOI: 10.1089/02724570050031194

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  8 in total

1.  Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Gilles W De Keulenaer; Catherine MacGillivray; Shin-ichi Tominaga; Scott D Solomon; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.

Authors:  Queen Henry-Okafor; Sean P Collins; Cathy A Jenkins; Karen F Miller; David J Maron; Allen J Naftilan; Neal Weintraub; Gregory J Fermann; John McPherson; Santosh Menon; Douglas B Sawyer; Alan B Storrow
Journal:  Open Biomark J       Date:  2012-04-20

3.  Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation.

Authors:  Tatsukuni Ohno; Keisuke Oboki; Hideaki Morita; Naoki Kajiwara; Ken Arae; Shizuko Tanaka; Masako Ikeda; Motoyasu Iikura; Taishin Akiyama; Jun-ichiro Inoue; Kenji Matsumoto; Katsuko Sudo; Miyuki Azuma; Ko Okumura; Thomas Kamradt; Hirohisa Saito; Susumu Nakae
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

4.  IL-33 and Airway Inflammation.

Authors:  Keisuke Oboki; Susumu Nakae; Kenji Matsumoto; Hirohisa Saito
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-15       Impact factor: 5.764

5.  Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells.

Authors:  Shin-Ichi Tominaga; Satoshi Ohta; Kenji Tago
Journal:  Biochem Biophys Rep       Date:  2015-11-21

6.  The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.

Authors:  Taro Ishiguro; Kinya Ishikawa; Makoto Takahashi; Masato Obayashi; Takeshi Amino; Nozomu Sato; Masaki Sakamoto; Hiroto Fujigasaki; Fuminori Tsuruta; Ricardo Dolmetsch; Takao Arai; Hidenao Sasaki; Kazuro Nagashima; Takeo Kato; Mitsunori Yamada; Hitoshi Takahashi; Yoshio Hashizume; Hidehiro Mizusawa
Journal:  Acta Neuropathol       Date:  2009-12-31       Impact factor: 17.088

Review 7.  Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.

Authors:  Ari B Molofsky; Adam K Savage; Richard M Locksley
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

8.  Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.

Authors:  Thomas Mueller; Benjamin Dieplinger
Journal:  EJIFCC       Date:  2016-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.